BioCentury
ARTICLE | Company News

Allelix deal

January 9, 1995 8:00 AM UTC

The Mississauga, Ontario, company and Eli Lilly Canada Inc. (Scarborough, Ontario) signed an four-year, C$15 million basic research agreement under which the companies will develop a new neuroreceptor target. ...